Date	Chamber	Action
1/13/2021	House	Session Sine Die

Statutes Amended In Order of Appearance

410 ILCS 50/3

from Ch. 111 1/2, par. 5403

Synopsis As Introduced
Amends the Medical Patient Rights Act. Provides that a patient or representative of the patient must give informed consent, or informed permission in the case of an infant, for biochemical testing for controlled substances unless there is a medical emergency and there is inadequate time to obtain consent. Describes the specific information that health care providers to supply to a patient, or a patient’s representative, before informed consent can be given. Effective immediately.

Actions 

Date	Chamber	Action
2/15/2019	House	Filed with the Clerk by Rep. Robyn Gabel
2/15/2019	House	First Reading
2/15/2019	House	Referred to Rules Committee
2/21/2019	House	Added Co-Sponsor Rep. Kelly M. Cassidy
3/5/2019	House	Assigned to Health Care Licenses Committee
3/19/2019	House	Added Co-Sponsor Rep. Will Guzzardi
3/21/2019	House	Added Co-Sponsor Rep. Jay Hoffman
3/27/2019	House	Do Pass / Short Debate Health Care Licenses Committee; 009-005-000
3/29/2019	House	Placed on Calendar 2nd Reading - Short Debate
4/4/2019	House	House Floor Amendment No. 1 Filed with Clerk by Rep. Robyn Gabel
4/4/2019	House	House Floor Amendment No. 1 Referred to Rules Committee
4/10/2019	House	Second Reading - Short Debate
4/10/2019	House	Held on Calendar Order of Second Reading - Short Debate
4/12/2019	House	Rule 19(a) / Re-referred to Rules Committee
1/13/2021	House	Session Sine Die

Back To Top